Ossur hf
CSE:OSSR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Navidea Biopharmaceuticals Inc
OTC:NAVB
|
US |
|
I
|
Ianthus Capital Holdings Inc
CNSX:IAN
|
CA |
Ossur hf
Other Current Assets
Ossur hf
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Ossur hf
CSE:OSSR
|
Other Current Assets
$40.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
17%
|
CAGR 10-Years
14%
|
|
|
Embla Medical hf
CSE:EMBLA
|
Other Current Assets
$45.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Ossur hf
Glance View
Össur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Össur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Össur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Össur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.
See Also
What is Ossur hf's Other Current Assets?
Other Current Assets
40.5m
USD
Based on the financial report for Mar 31, 2024, Ossur hf's Other Current Assets amounts to 40.5m USD.
What is Ossur hf's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
14%
Over the last year, the Other Current Assets growth was 29%. The average annual Other Current Assets growth rates for Ossur hf have been 5% over the past three years , 17% over the past five years , and 14% over the past ten years .